X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ACTAVIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
ACTAVIS
Dec-14
UNICHEM LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs38219,794-   
Low Rs23412,074-   
Sales per share (Unadj.) Rs116.33,564.4-  
Earnings per share (Unadj.) Rs-18.9-444.8-  
Cash flow per share (Unadj.) Rs-11.7327.0-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.07,731.1-  
Shares outstanding (eoy) m70.34265.90-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.64.5 59.3%   
Avg P/E ratio x-16.3-35.8 45.4%  
P/CF ratio (eoy) x-26.248.7 -53.9%  
Price / Book Value ratio x0.82.1 39.2%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6684,236,897 0.5%   
No. of employees `0002.321.6 10.6%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.843,878.6 8.2%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.7-5,475.6 10.7%   
INCOME DATA
Net Sales Rs m8,180947,779 0.9%  
Other income Rs m610-2,365 -25.8%   
Total revenues Rs m8,790945,413 0.9%   
Gross profit Rs m-1,320121,756 -1.1%  
Depreciation Rs m505205,229 0.2%   
Interest Rs m8029,895 0.3%   
Profit before tax Rs m-1,295-115,733 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-8,490 0.0%   
Tax Rs m33-5,950 -0.6%   
Profit after tax Rs m-1,331-118,273 1.1%  
Gross profit margin %-16.112.8 -125.6%  
Effective tax rate %-2.65.1 -50.2%   
Net profit margin %-16.3-12.5 130.4%  
BALANCE SHEET DATA
Current assets Rs m23,318499,358 4.7%   
Current liabilities Rs m4,635364,179 1.3%   
Net working cap to sales %228.414.3 1,601.3%  
Current ratio x5.01.4 366.9%  
Inventory Days Days12258 209.9%  
Debtors Days Days12166 183.3%  
Net fixed assets Rs m8,163115,733 7.1%   
Share capital Rs m1410-   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,8012,055,697 1.3%   
Long term debt Rs m31,077,226 0.0%   
Total assets Rs m31,8903,767,417 0.8%  
Interest coverage x-15.2-2.9 528.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.3 102.0%   
Return on assets %-3.9-2.3 167.2%  
Return on equity %-5.0-5.8 86.3%  
Return on capital %-4.5-3.0 150.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,123162,752 -0.7%  
From Investments Rs m16,487-389,691 -4.2%  
From Financial Activity Rs m-8,811218,950 -4.0%  
Net Cashflow Rs m6,552-7,989 -82.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.56 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: DIVIS LABORATORIES  ALEMBIC LTD  TTK HEALTHCARE  CADILA HEALTHCARE  GLENMARK PHARMA  



Today's Market

Sensex Opens Flat; Capital Goods & Banking Stocks Lag(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.5% while the Hang Seng is down 1.2%.

Related Views On News

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 13, 2018 10:37 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS